Showing results (2521-2530 of 2,542) with videos related to

Sort By:
Pageof 255
Scientific Reports|September 15, 2017
Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & CancerHuân M Ngô, Ying Zhou, Hernan Lorenzi, et al.
Blood Cancer Journal|March 27, 2024
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?Ing Soo Tiong, Meaghan Wall, Ashish Bajel, et al.
Scientific Reports|April 7, 2020
Author Correction: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infectionsMartin McPhillie, Ying Zhou, Kamal El Bissati, et al.
Scientific Reports|July 15, 2016
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infectionsMartin McPhillie, Ying Zhou, Kamal El Bissati, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Blood|August 30, 2023
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLGSun Loo, Andrew W Roberts, Natasha S Anstee, et al.
Clinical Genetics|August 19, 2014
Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorderA Chaudhry, A Noor, B Degagne, et al.
Frontiers in Cellular and Infection Microbiology|July 7, 2020
Potent Tetrahydroquinolone Eliminates Apicomplexan ParasitesMartin J McPhillie, Ying Zhou, Mark R Hickman, et al.
Blood|April 7, 2021
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemiasRachel Thijssen, Sarah T Diepstraten, Donia Moujalled, et al.
Cancer Discovery|September 27, 2018
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established TherapiesSean Caenepeel, Sean P Brown, Brian Belmontes, et al.
Pageof 255